AVVA is a research-based pharmaceutical company that discovers, develops and commercializes innovative medicines that address common medical needs, discoveries based on the human microbiome research. We simplify medical care by improving the efficacy and safety profile of commonly used medication, thus enhancing the current therapeutic approach.

we are an industry leader in the development and production of innovative medicines that address common medical needs, building on its knowledge derived from the research of the human microbiome.

Our portfolio includes a number of inventions that will replace current standards in the field of infectious and metabolic diseases.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator